{"id":789,"date":"2025-09-03T03:53:19","date_gmt":"2025-09-03T03:53:19","guid":{"rendered":"https:\/\/majic.jp\/?p=789"},"modified":"2025-09-03T03:55:55","modified_gmt":"2025-09-03T03:55:55","slug":"regarding-the-recent-series-of-reports-on-cbd-products-following-the-resignation-of-a-listed-company-chairman","status":"publish","type":"post","link":"https:\/\/majic.jp\/en\/news\/regarding-the-recent-series-of-reports-on-cbd-products-following-the-resignation-of-a-listed-company-chairman\/","title":{"rendered":"Regarding the Recent Series of Reports on CBD Products Following the Resignation of a Listed Company Chairman"},"content":{"rendered":"\n

In connection with the series of reports on CBD products that accompanied the resignation of a listed company chairman reported on September 2, 2025, we have observed coverage that gives the impression that CBD is involved, or even that CBD is synonymous with THC.<\/p>\n

The Japan Medical & Industrial Cannabis Association (MAJIC) would like to emphasize, in light of recent reports\u2014including alleged violations concerning products containing THC reported on September 2, 2025\u2014our unwavering commitment to consumer safety and strict compliance with Japan\u2019s Cannabis Control Act.<\/i><\/i><\/p>\n

Our top priority is ensuring consumer safety and peace of mind. When using CBD products, we ask that consumers keep the following in mind:<\/p>\n

\u00a0<\/p>\n